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Objective: Human papillomavirus (HPV) testing has been proposed for inclusion in the UK cervical
screening programme. While testing may bring some benefits to the screening programme, testing positive
for HPV, a sexually transmitted virus, may have adverse social and psychological consequences for
women. The aim of this study was to examine the social and psychological impact of HPV testing in the
context of cervical cancer screening.
Method: In-depth interviews generating qualitative data were carried out with 74 women participating in
HPV testing in England between June 2001 and December 2003. Purposive sampling was used to ensure
heterogeneity in age, ethnic group, marital status, socioeconomic background, cytology, and HPV results
among participants.
Results: Testing positive for HPV was associated with adverse social and psychological consequences,
relating primarily to the sexually transmitted nature of the virus and its link to cervical cancer. Women
described feeling stigmatised, anxious and stressed, concerned about their sexual relationships, and were
worried about disclosing their result to others. Anxiety about the infection was widespread, but the impact
of testing positive varied. The psychological burden of the infection related to women’s relationship status
and history, their social and cultural norms and practices around sex and relationships, and their
understanding of key features of HPV.
Conclusion: HPV testing should be accompanied by extensive health education to inform women and to
de-stigmatise infection with the virus to ensure that any adverse impact of the infection on women’s
wellbeing is minimised.
H
uman papillomavirus (HPV) testing has the potential
to change conventional methods of cytological screen-
ing. Five million women take part in cervical screening
each year in the United Kingdom alone and any changes to
incorporate HPV testing would have a widespread impact.
HPV triage testing for women with mild cervical abnormal-
ities has received much attention and is fast becoming part of
routine care in the United States.
1–6 In the United Kingdom,
trials of HPV triage testing and primary screening are
currently under way to inform potential changes to the
national screening programme.
7–9
Although HPV testing offers potential advantages over
conventional cervical screening,
13it may have implications
for the psychological wellbeing of women who participate.
10
The psychological effects of an abnormal smear result are
well researched
11 12; however, the sexually transmitted nature
of HPV infection means it may cause additional anxiety and
distress. At present women have very little understanding of
HPV and its association with cervical cancer,
13–15 therefore any
information given as part of HPV testing is likely to change
their understanding of cervical cancer, which may in turn
impact on their psychological response. Research investigat-
ing the psychosocial consequences of other sexually trans-
mitted infections (STIs) suggests the impact of diagnosis can
be extremely negative.
16 17 Although there has been much
clinical and economic evaluation of HPV testing, attention to
the psychosocial consequences of testing has been limited.
18 19
Existing research suggests that testing positive may be
associated with some negative psychological outcomes,
20 21
but there has been no in-depth examination of the social and
psychological consequences of HPV infection among women
who have actually participated in HPV testing.
13 22
This paper presents the first qualitative data on the
psychological and social impact of testing for high risk HPV
among British women participating in HPV testing, either as
part of a clinical trial, or specialist gynaecological manage-
ment for their abnormal cervical smear. The study was
designed to access a broad range of views and experiences so
women from different ethnic groups and socioeconomic
backgrounds were included.
METHOD
Participants
A total of 74 women were recruited in Manchester and
London from clinical trials of HPV testing and from
colposcopy clinics where HPV testing is carried out as part
of routine care. Most participants had an HPV test at the
same time as their routine smear, but for some, testing was
offered alongside colposcopy following abnormal cytology
results. All participants had received their test results (HPV
and smear). Within each centre, all women had been given
standardised information about HPV, although there was
some variation in the detail between centres.
We used non-random, purposive sampling
23 to ensure
heterogeneity with respect to age, marital status, socio-
economic background, and cytology result. Women from
three broad ethnic groups were included: white British, south
Asian (including Pakistani, Indian, and east African Asian)
and African Caribbean. These groups have been shown to
differ in attitudes towards sexual health
24 and uptake of
cervical screening.
25 Women who had tested positive or
negative on the Digene HCII HPV test were included.
Abbreviations: CIN, cervical intraepithelial neoplasia; GPs, general
practitioners; HPV, human papillomavirus; STI, sexually transmitted
infections
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In-depth interviews were carried out with women, usually in
their own homes. Interviews were structured around a topic
guide (see table 1) which encouraged the individual to
respond freely to open ended questions relevant to their
experience. The topic guide provides a flexible set of content
areas to direct the interview process while allowing the
participants’ experience to influence the specific content and
direction of the interview.
26 Interviews were carried out by
the first and second authors and trained freelance inter-
viewers, using a mixture of ethnic matching and mismatch-
ing. They were transcribed verbatim and translated by the
interviewer where necessary.
Framework analysis was used to organise the data and
identify emerging themes.
26 The thematic framework is
developed through familiarisation with a subset of tran-
scripts. All data are summarised within the matrix to allow
relationships and explanations for patterns within the data to
be explored.
RESULTS
Participant characteristics are shown in table 2 and demon-
strate the heterogeneity of the sample. The data were
examined to understand the impact of HPV testing on
women and to explore how and why the impact varied. The
analysis presented here focuses mainly on the 57 women who
were HPV positive. Women’s responses were clustered
around two main themes, the first relating to anxiety about
HPV in the context of increased risk of cervical cancer, and
the second relating to the meaning, consequences, and
understanding attached to the HPV infection (see table 3).
General psychological wellbeing
Women’s general response to a positive HPV test result was
one of distress, anxiety, and upset. Women described feeling
shocked at receiving a diagnosis of an infection of which they
had little previous awareness or understanding. This was
combined with anxieties about cancer risk, concerns about
further investigation/treatment for cervical intraepithelial
neoplasia (CIN), and worries about fertility; concerns which
have been found to commonly accompany an abnormal
smear result, even in the absence of HPV testing. The extent
of anxiety some women described included intrusive
thoughts and somatic responses to the diagnosis during the
period when they first received their test results,
N ‘‘I was looking really ill. I wasn’t sleeping. It was kind of
nearly every day I was thinking about it’’ (W23 HPV+
CIN2)
(Participant ID numbers use W, SA, and AC to denote white, south
Asian, and African Caribbean women, respectively.)
Anxieties relating to cervical cancer are well described
elsewhere
11 12 and will not be the focus of the current paper.
The following data will therefore relate specifically to issues
raised by the diagnosis of HPV infection.
Concerns relating to the meaning, consequences, and
understanding of HPV
Much of the concern which emerged about testing positive
for HPV related to the sexually transmitted nature of the
infection. This affected women across a number of social,
emotional, and behavioural dimensions.
Stigma of an STI
Shock, embarrassment, and shame were common responses
to the infection, with women using terms such as ‘‘unclean,’’
‘‘dirty,’’ ‘‘cheap and nasty’’ to describe how they felt in
response to their positive HPV result.
Table 1 Topic guide
Topic guide
1 Background demographic information
2 Screening history and background knowledge
3 Information and understanding of HPV test
4 Experience of recent Pap test results, HPV diagnosis
5 Understanding and perceptions of results
6 Disclosure of results to others
7 Emotional impact of results
8 Experience of treatment or follow up
9 Improvements to cervical screening in the future
Table 2 Demographic characteristics of the sample
(n=74)
Demographic characteristics No
Age
20–29 22
30–39 27
40–49 16
50–64 9
Relationship status
Single 20
In a relationship (not cohabiting) 10
Cohabiting 11
Married 24
Divorced/separated/widowed 9
Education
Left school before 16/no qualifications 10
Left school at 16 (GCSEs, CSEs, O levels) 13
Further education (diploma, BTech, etc) 12
Higher education (degree) 33
Missing data 6
Ethnic group
White 41
South Asian 17
African Caribbean 16
Cytology result
Normal 34
Abnormal 40
HPV result
Positive 57
Negative 17
Table 3 Table of themes: psychological and social
responses to HPV testing
(1) Social and psychological response
A General psychological responses
shock, distress, worry
concerns about cancer
reassurance of additional testing
B Concerns relating to the sexually transmitted nature of HPV
Stigma of STI
Guilt and blame for the cause of the infection
Anxiety about disclosure to sexual partners
Anxiety about disclosure to family and friends
Concerns about transmitting the infection
(2) Factors influencing social and psychological response
A Women’s relationship status and history
B Social, cultural and religious norms around sex and relationships
C Understanding of HPV
Extremely common infection
Can regress without treatment
No visible physical signs, distinct from genital warts and herpes
Treatment for CIN is highly effective
Condoms do not necessarily prevent infection
Not necessary to inform sexual partners
Impact on male sexual partner likely to be negligible
Need for consistent of information
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there’s a leper type deal to it.’’ (W24 HPV+ normal smear)
Such reactions suggest connotations of promiscuity sur-
rounding HPV that were linked to its mode of transmission
and perceived connection with genital warts.
N ‘‘The stigma comes from it being sexually transmitted and
the fact that it not only predisposes you to cancer but it
predisposes you to genital warts and other things like
that.’’ (SA3 HPV+ normal smear)
Confusion between high risk HPV types and low risk
genital wart types was common and was linked to use of the
term ‘‘wart virus’’ in information provided to women about
HPV, and confusion among healthcare providers themselves
about the different viral types. Notably, feelings of stigma
and shame were not displayed among women who were
unaware that HPV is sexually transmitted, suggesting an
additional burden that awareness of HPV can bring.
The stigma associated with HPV also impacted on women’s
feelings about sex and their sexual relationships. Some
women said they felt ‘‘dirty’’ and therefore sexually
unattractive. Others reported feeling ‘‘infected’’ or that
something was ‘‘growing inside them’’ and were worried
about transmitting the infection. Some seemed to be more
affected by concerns that the physical act of sex would
worsen their abnormal cells. However, there were also
women who were clearly aware of the route of transmission
but who did not attach any stigma or personal feelings of
embarrassment or shame to it. Among this group of women,
common STIs such as HPV were seen an inevitable part of
sexual activity.
N ‘‘A normal thing for many women to have.’’ (SA2 HPV+
normal smear).
G u i l ta n db l a m ef o rt h ec a u s eo ft h eH P Vi n f e c t i o n
Searching for an understanding of who caused the infection
was a common response. Some women described feeling
angry that a previous partner had infected them with what
they perceived as a serious and carcinogenic virus. Others felt
guilty that they had acquired the infection by being careless
or promiscuous. Some blamed themselves for trusting some-
one who had later let them down. Others described
questioning whether their partner had been unfaithful;
however, most of these women ultimately attributed the
infection to another source, such as a previous partner.
N ‘‘Actually I think I had it anyway, I must have had it
before I started seeing my partner now.’’ (AC4 HPV+
abnormal smear)
Where it was known that infidelity had occurred, feelings
of considerable anger and upset were elicited and some
women re-experienced the negative feelings that were
associated with the infidelity.
N ‘‘He was actually having an affair with my best friend and
I suspected… I kept saying are you, are you, are you? … A
double betrayal plus ill health … I feel that it was very
unlucky that my first lover should have done this.’’ (W25
HPV+ CIN1)
The influence of relationship status and history
Women’s response to their HPV test result varied and seemed
to be influenced in part by the status and history of their
primary sexual relationships. For example, in relationships
where there had been recent discord, infidelity, or had ended
unhappily, the HPV test result led to questions about
trust and fidelity and accusations of blame for the infection.
One woman highlighted the significance of the HPV result
in the context of her marriage and her husband’s recent
affair.
N ‘‘I did worry about my husband not being a good boy … I
remember saying to my husband if this is positive this is
going to be hard … when I die of cervical cancer you’ll be
sorry … I think it was the fact that I’d been married for so
long and it was like where’s that come from sort of thing?
But if I was in my twenties and having lots of partners
then it wouldn’t have been such a big deal … It [the affair]
really shook our marriage up and I never thought I’d be
able to stay with him. And it was like this [HPV] was
something I hadn’t even thought of coming out to get me
just when I thought it [the affair] had been dealt with.’’
(W24 HPV+ normal smear)
For women entering new relationships testing positive led
to worries about transmitting the infection to their new
partner and anxieties about disclosing their infection to
someone they had only recently met. In contrast, in more
established relationships where there had been openness
about previous sexual relationships, the HPV was simply
attributed to a previous partner and appeared to cause little
problem.
N ‘‘My husband could have been the carrier or boyfriends I
had before him. Or somebody afterwards. It could have
been anybody. It’s not something that they’re likely to
know they’ve got either. So I just thought well I have it so
that’s where we are.’’ (W28 HPV+ mildly abnormal smear)
Disclosure
Women repeatedly described anxiety about disclosing their
HPV positive test result to their partner or family and friends.
For some, the stress of disclosure appeared to be the most
difficult aspect of managing the HPV infection.
Disclosure to sexual partners
Women reported feeling highly anxious about informing
their partner, with descriptions of ‘‘bursting into tears’’ and
feeling intensely ‘‘guilty’’ and worried that they may have
infected their partner with the virus.
N ‘‘I’ve infected him and this is the man I want to spend the
rest of my life with…how am I going to tell him?’’ (W31
HPV+ CIN3)
The underlying concern about the disclosure centred on
embarrassment and shame about the promiscuity attached to
an STI and also a fear of being sexually rejected.
N ‘‘If I told men that I had it they might not want to have sex
with me.’’ (W2 HPV+ CIN2)
To manage the anxiety many women chose not to tell their
partner about their HPV infection, instead focusing on their
abnormal cytology result which did not carry direct connota-
tions of sexual transmission. In other cases women described
being deliberately vague about how HPV was transmitted or
playing up their own confusion:
N ‘‘I have told my partner that they don’t know where it
comes from … obviously because he’d look at me in a
different light because … he’d be like, have I got it or has
she been with somebody else?’’ (W13 HPV+ normal
smear)
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on the information that the HPV infection had no impact on
their partner and disclosure was therefore unnecessary. In
other cases, women did not know what they should tell their
partner and in the absence of clear advice simply elected not
to say anything. This decision was motivated by women’s
desire to minimise their own anxiety during an already
stressful period and to avoid dealing with a difficult issue of
which they had only limited understanding.
N ‘‘It seemed easier and less stressful not to tell him and it
was nothing that was going to affect him physically.’’ (W6
HPV+ CIN1)
In contrast, where previous sexual activity was freely
acknowledged and accepted, women found no difficulty in
confiding in their partner, although the HPV infection was
typically attributed to a previous partner.
N ‘‘He was really supportive about it. It was me saying to
him it’s because I’ve been stupid and blah blah … and he
was saying well maybe it’s not, how do you know?’’ (W35
HPV+ CIN2-3)
Disclosure to family and close friends
Women were also highly anxious about talking to family
members. Some women chose not to tell anyone, others gave
family and friends information only relating to their smear
result rather than HPV. Again, worries around disclosure
centred on concern about the stigma of an STI and its
associations with promiscuity.
N ‘‘I lied, I told them irregular activity, I didn’t say HPV. I
only told my sister when I knew I didn’t have it [I didn’t
want people saying that I had a] genital wart problem or
weird STD thing … association of genital warts isn’t
great.’’ (W4 HPV+ normal smear)
Those who did tell friends and family reported them being
supportive and helpful, although a few described negative
experiences.
N ‘‘My mum was like, ‘I told you so’ … it’s not something
you really want to hear.’’ (W35 HPV+ CIN2-3)
The role of social, cultural, and religious norms
around sex and relationships
Women’s norms and practices around sex and relationships
emerged as an important in influencing their ability to
disclose the result to others and draw on social and emotional
support. This was most apparent among some of the south
Asian women, particularly younger unmarried south Asian
women who hid their sexual relationships from their parents.
In this context attendance for cervical screening per se was
seen as an indicator of sexual activity and was hidden.
N ‘‘I don’t even know if my mum’s ever had a smear test and
she must have done she’s had three kids. But it’s not
something we ever spoke about. So it’s one of those
forbidden topics of conversation as sex is. The only time
my mum ever spoke to my sister about sex was the day
before her wedding day and she’s never spoken to me
about it.’’ (SA6 HPV2 normal smear)
In this context, it was not possible for women to disclose
either their HPV or cytology result. For some women this was
described as contributing to the anxiety that they felt
following their positive result.
N ‘‘I mean the emotional pressure that you are under, I mean
nobody knows that I have a partner, and then to find out
that you have something like this, you just think to
yourself maybe I shouldn’t have done this in the first place
and then I wouldn’t be in this situation today. So there is
all this guilt as well as everything else.’’ (SA2 HPV+
normal smear)
However, other south Asian women seemed comfortable in
excluding their parents from discussions that in any way
related to sex or relationships, instead they gained social and
emotional support from their friends, sisters, and partners.
In contrast, African Caribbean and white British women
rarely spoke about hiding information on standard cervical
screening, and most of them seemed reasonably comfortable
discussing an abnormal smear result. However, they were
concerned about disclosing to others that they had HPV. As
such, HPV testing presented a change to how and with whom
their cervical screening results were discussed, in effect
becoming stigmatised and taboo, not dissimilar to the south
Asian women’s response to smears. There were also
similarities between the south Asian group and the white
British and African Caribbean women with strong religious
beliefs. Among these women there was some existing stigma
around an abnormal smear, and a direct link with sexual
activity and promiscuity.
N ‘‘I had this association in my head, an old Catholic thing
that um … promiscuity and cell changes would go
together.’’ (W17 HPV+ CIN2)
Understanding of HPV
Although understanding that HPV was sexually transmitted
was central to women’s response, there were other key
features of knowledge about HPV that also seemed to be
closely associated with the psychological and social burden
imposed by the infection.
27 Understanding that HPV is an
extremely common infection and can potentially clear up on
its own appeared to reduce the stigma and embarrassment
some women felt. Indeed, HPV was likened to infections that,
while possibly sexually transmitted, are common and
accepted such as candida.
N ‘‘I was under the belief that it could go away on its own. I
presumed that it was, because it was a common
thing…um the initial thing I read…suggested that it can
sort of clear up on its own.’’ (W7 HPV+ normal smear)
Awareness that there are no visible physical symptoms, in
particular, genital warts, and understanding that treatment
for CIN is highly effective also appeared important to
reassure women. In contrast, where women were still
worried about the development of genital warts or confused
HPV with other symptomatic STIs such as herpes, there
seemed to be considerable distress.
There was also concern about the risk of spreading HPV
infection and confusion about the protective role of condoms.
One participant described having sex with a new partner
when the condom broke.
N ‘‘I was absolutely terrified that I would pass on the
infection.’’ (W23 HPV+ CIN2)
Another woman described concern that she had passed
HPV to her ex-partner during unprotected sex. She was
unsure and worried whether to inform him so that he could
warn future partners of the risk. Understanding that the
impact of HPV on men was negligible and condoms did not
necessarily prevent infection therefore appeared to alleviate
considerable anxiety. Importantly, it meant that there was no
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which allowed women to avoid the challenges of disclosure,
such as embarrassment, fear about rejection, and damage to
their reputation. Understanding of the limits of condoms also
seemed to help women feel less to blame for contracting or
passing on the HPV infection.
It was also apparent that poor understanding of the virus
among partners, family, and friends enhanced anxiety
around disclosure. In some cases women had to challenge
prejudiced beliefs and defend their reputations to others
armed with only a little information. Taking on the burden of
explaining something poorly understood, particularly to a
partner, was described as extremely difficult. Women also
reported receiving inconsistent information from health
professionals, which contributed to their confusion and
distress about the infection.
N ‘‘What really, really bothered me was the lack of consistent
clear information … one health clinic in one hospital, they
would say right this can completely be cleared up. And
then I’d speak to someone else and they’d say no don’t be
silly it’s a virus you’ve got it for life. And then someone
else would say you’re going to get warts and somebody
else would say you’re not going to get warts it’s a different
strain of the virus. And someone would say a condom will
not protect you it’s sexually transmitted. And I would say
what’s the protocol here? Should I be telling sexual
partners that I have this? And one person would say yes of
course you must and another would say don’t be silly
almost all the population’s been exposed to it. And there
was such a conflict of information, that was what really
upset me. I couldn’t get to the truth ….they were giving
me conflicting advice. … I found that very distressing that
I couldn’t actually get real information that I could trust.’’
(W17 HPV+ normal smear)
CONCLUSION
The findings suggest that testing positive for HPV was
associated with adverse social and psychological conse-
quences that were beyond those experienced by an abnormal
smear alone. These related primarily to the sexually
transmitted nature of the virus, which led to stigma and
anxiety about the virus and concern about sexual relation-
ships. In particular, women were worried about disclosing
their result to their partner and their family, restricting their
usual channels of support. Although anxiety about the
infection was widespread, the impact of testing positive
varied in relation to the women’s relationship experience,
social and cultural norms, and practices around sex and
relationships, and women’s understanding of key features of
the virus.
The findings of this qualitative study are highly consistent
with quantitative studies of the psychological impact of HPV
infection
20 21 and other STIs.
16 17 28 29 They also contribute to
our understanding of the underlying processes influencing
psychological and social responses and provide a starting
point to explain the variation in women’s response through
their relationships, norms, and understanding of HPV. The
study is strengthened by its inclusion of a socially and
ethnically heterogeneous sample who had participated in
HPV testing in a variety of clinical settings, and the use of a
qualitative approach to understand the complexities of how
women respond to HPV infection. The results suggest that
HPV testing imposes an additional social and psychological
burden on women beyond that already experienced in
conventional cytology screening and the findings have
implications for plans to include HPV testing in national
cervical screening programmes in the United Kingdom and
worldwide.
The results highlight the crucial role of information about
HPV in moderating the experience of women taking part in
testing. It suggests that clear consistent information about
key features of HPV, such as its high prevalence, the
distinction between high risk types and genital warts, and
the implications for sexual partners and disclosure, may
alleviate some important anxieties. This hypothesis needs to
be carefully tested, but on the basis of these results it seems
that clear standardised information should be made available
and screening providers should consider carefully the
information and advice they give to women participating in
cervical screening. The burden of information provision may
fall to general practitioners (GPs) who carry out the majority
of smear tests in the United Kingdom and in many other
countries. It is well known that GPs find discussion of sex
and STIs with patients extremely difficult,
30 particularly with
older patients,
31 so support may be important.
HPV testing is complex for lay people and health
professionals alike. The challenge will be to communicate
information to women in a way that ensures they understand
the facts while limiting their anxiety and the sense of stigma
around the infection. We have a responsibility to ensure that
women who are encouraged to participate in cervical
screening and HPV testing are adequately informed so that
the social and psychological harm of detecting HPV is
minimised.
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